ROBO Global Q1 Investor Call 2020

The ROBO Global innovation indices outperformed during the worst quarter for global equities since 2008. The Robotics & Automation Index (ROBO) declined 20% in Q1, while the Artificial Intelligence Index (THNQ) lost 15%, and the Healthcare Technology & Innovation Index (HTEC) was down 11%. We expect the COVID-19 crisis to remain a relatively short-term event. And with strong balance sheets and a small-mid-cap tilt, the ROBO Global index portfolios are well-positioned to continue to outperform in the current environment. In this report, we discuss key sector trends and big movers.

ROBO Global Q4 Investor Call 2019

The ROBO Global innovation indices closed 2019 on a strong note, largely outperforming global equities. The Robotics & Automation Index (ROBO) returned 30.3% for the year, the Artificial Intelligence Index (THNQ) increased 37.6%, and the Healthcare Technology & Innovation Index (HTEC) rose 34.9%. The good news is that earnings growth has only just inflected and looks set to return to the double-digits in 2020.

Investing in HTEC: Healthcare Technology & Innovation Index by ROBO Global

Healthcare is undergoing massive disruption, creating an incredible, long-term investment opportunity. ROBO Global, the creators of ROBO, the first robotics & AI index, bring you HTEC. HTEC is an investment portfolio dedicated to providing exposure to best-in-class healthcare technology companies around the world.

ROBO Global Q3 ’19 Investor Call

Nine months into the year, the ROBO Global Robotics & Automation Index (ROBO) has returned more than 17%, the Artificial Intelligence Index (THNQ) has increased 23%, and the Healthcare Technology & Innovation Index (HTEC) is up 19%. After two consecutive quarters of earnings declines, ROBO’s median EPS growth appears to have turned positive in 3Q19 and is set to return to double-digits in 2020. In this investor call, we discuss key trends and big movers.

Tabula Rasa Spotlight: An Inside Look with ROBO Global

In this video segment Nina Deka, Senior Research Analyst at ROBO Global, speaks with the management team at Tabula Rasa HealthCare to learn how the company is using data analytics to manage medication risk and keep people out of hospitals. Adverse drug events account for over 125,000 hospital admissions each year at a hefty cost to the healthcare system of ~$30B. The unfortunate truth is that the vast majority of these events are caused by medication errors that could have been prevented. A member of the ROBO Global HTEC Index, Tabula Rasa provides patient-specific, data-driven technology and solutions that help healthcare organizations lower costs and improve the overall health and well being of their patients.

ROBO Global Q2 ’19 Investor Call

Robotics, automation, and AI stocks rose in Q2, pushing the ROBO Index up 22% year-to-date. Watch the recording of our Q2 investor call where you’ll hear more about the recent trends in robotics and AI investments and learn about our newest index, Healthcare Technology & Innovation

ROBO Global Q1 Investor Call 2019

The ROBO Global Index was up 18% in the first quarter of 2019. Our research team will walk you through the key trends, companies and subsectors driving the performance as well as discuss key updates made to the index in the March rebalance.

Meet the Minds Behind the ROBO Global Strategic Advisory Board

Henrik Christensen, Illah Nourbakhsh, and Manish Kothari are just three of the brilliant members of the ROBO Global Strategic Advisory Board. Among the top minds in the world of robotics and AI, we are honored to have their insight and knowledge fueling the decisions behind the index and helping to keep ROBO state of the art in the realm of robotic developments.

iRobot CEO Spotlight: A Behind the Machines Look with ROBO Global

In this one-on-one interview with iRobot CEO Colin Angle at the company's Bedford, MA, headquarters, Jeremie Capron, ROBO Global's Director of Research, takes us on an insider's tour of iRobot to learn what's driving the growth for this leader in the consumer robotics sector.

Giving investors a way into robotics and automation (Proactive Investors)

Richard Lightbound, ROBO Global's CEO EMEA, talks to Proactive in this interview about the ROBO Global Robotics & Automation Index that is designed specifically to give investors targeted access to the entire and fast-growing global supply chain of robotics and AI.

load more

You are now leaving the ROBO Global website

You are now leaving the ROBO Global website. The following landing page may contain information concerning investments, products or other information. Exchange Traded Concepts LLC, the Fund Advisor are not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by the entities that are not affiliated with Exchange Traded Concepts LLC. Descriptions of, references to, or links to products or publications within any non-affiliated linked website does not imply endorsement of that product or publication by Exchange Traded Concepts LLC. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of Exchange Traded Concepts LLC, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETF Securities (UK) Limited which is authorized and regulated by the United Kingdom Financial Conduct Authority (the “FCA”). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). IN addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETF Securities (UK) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETF Securities (UK) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETF Securities (UK) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETF Securities (UK) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss

You are now leaving the ROBO Global website

You are now leaving the ROBO Global, LLC website and being directed to ETFS Management (AUS) Limited which is authorized and regulated by the Australian Securities and Investments Commission (“ASIC“). By clicking “OK”, you acknowledge that you are someone authorized to undertake investment activities relating to the Exchange Traded Funds (ETFs). In addition, you understand that ROBO Global, LLC is not making any financial promotion or carrying out any regulated activity of said products. The following landing page may contain information concerning investments, products or other information. ETFS Management (AUS) Limited is not responsible for the accuracy or completeness of information on non-affiliated websites. The material available on non-affiliated websites has been produced by entities that are not affiliated with ETFS Management (AUS) Limited. Descriptions of references to, or links to products or publications within any non-affiliated linked websites does not imply endorsement of that product or publication by ETFS Management (AUS) Limited. Any opinions or recommendations from non-affiliated websites are solely those of the independent providers and are not the opinions or recommendations of ETFS Management (AUS) Limited, which is not responsible for any inaccuracies or errors.

Proceed

Dismiss